Evaluation reports EN

ACTION - Actions for oncogenesis understanding and target identification in oncology

Type: Research entity evaluation report
Evaluation campaign: 2014-2015 (group A) - Published on: 01/06/2015
Institution(s) concerned: Université de Bordeaux , Institut national de la santé et de la recherche médicale - INSERM
Disciplinary research field: Life and Earth Sciences (SVE); SVE2 Cellular Biology, Imaging, Molecular Biology, Biochemistry, Genomics, Systemic Biology, Development, Structural Biology; SVE5 Physiology, Physiopathology, Cardiology, Pharmacology, Enocrinology, Cancer, Medical Technologies
Scientific field(s): 5 - Biologie, medecine et santé
ERC panel(s): LS1 Molecular and Structural Biology and Biochemistry: molecular biology, biochemistry, biophysics, structural biology, biochemistry of signal transduction; LS3 Cellular and Developmental Biology: cell biology, cell physiology, signal transduction, organogenesis, developmental genetics, pattern formation in plants and animals; LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics
Name of unit teams: Oncogenesis and Therapeutic Targeting of the Sarcoma Cell (ONCOSARC); Genetic Diversity and Resistance to Therapy: Mammary and Leukemic Oncogenesis (LMLO); Validation and Identification of New Targets in cancer and AGEing (VINTAGE)
Keywords: Biologie cellulaire; biologie moléculaire; génétique moléculaire; pharmacologie clinique; cancer; thérapies ciblées; vieillissement; sarcomes; cancer du sein; lymphomes; SVE2_1; SVE2_3; SVE2_2; SVE6

Download file